Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Psilocybin for Treatment of Obsessive Compulsive Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03300947

Organisation Name: University of Arizona

Overal Status: Suspended

Start Date: January 2, 2019

Last Update: August 18, 2020

Lead Sponsor: University of Arizona

Brief Summary: This study will evaluate whether psilocybin, a hallucinogenic drug, improves symptoms of obsessive compulsive disorder (OCD), whether it is safely tolerated as treatment of OCD, and will investigate the mechanisms by which it works.

Conditions:
  • Obsessive-compulsive Disorder (OCD)


Total execution time in seconds: 0.15713095664978